02319nrm0 22002893i 450 SUN011065420180117120449.7240.0020170912f |0absc50 baabsUS*Mushroom Packaging[materiali naturali]Ecovative Design LLC1 campione di materialeGreen Island (NY), Stati UnitiEcovative Design LLC.Packaging made from agricultural waste materials and produced by living organisms. Regionally available agricultural by-products like cotton burrs, rice hulls, and buckwheat hulls that are high in lignin provide a growth medium for fungal mycelium, the roots of mushrooms. Producing the material requires extremely low energy because the material grows independent of lighting conditions, with no watering and no petrochemical input. The parts grow in about seven days, forming miles of tiny white fibers that envelop and digest the seed husks, and bind them to form the final product, which is dried to prevent further growth. The entire process uses about ten times less energy per unit of material than the manufacturing of synthetic foams. It has a density range of 6 – 8 lbs/ft³ (0.096 – 0.128 g/cm³). The product is 100% biodegradable and compostable. The material replaces expanded polystyrene custom molded foams, and is designed for use as a packaging material.ImballaggiARSUNC033156Green IslandSUNL002064Ecovative Design LLCSUNV085438630ITSOL20181109RICA/sebina/repository/catalogazione/documenti/070_MUSHROOM PACKAGING.docxScheda tecnica del materiale Clicca QUI per aprire il documento /sebina/repository/catalogazione/documenti/70mushroom.jpgImmagine del campione di materiale. Cliccarci sopra per ingrandirlohttp://www.mushroompackaging.com Sito del produttore SUN0110654BIBLIOTECA DEL DIPARTIMENTO DI ARCHITETTURA E DISEGNO INDUSTRIALE01 CM 70 01 ML 70 BIBLIOTECA DEL DIPARTIMENTO DI ARCHITETTURA E DISEGNO INDUSTRIALEIT-CE0107ML70CM 70caMushroom Packaging1466412UNICAMPANIA04504nam 2200649 a 450 991014484850332120170810195502.01-280-76875-497866136795290-470-71925-70-470-71676-2(CKB)1000000000687683(EBL)703771(OCoLC)775867436(SSID)ssj0000715178(PQKBManifestationID)11434928(PQKBTitleCode)TC0000715178(PQKBWorkID)10700526(PQKB)11300350(MiAaPQ)EBC703771(EXLCZ)99100000000068768319840321d1962 uy 0engur|n|---|||||txtccrCiba Foundation Symposium, jointly with Co-ordinating Committee for Symposia on Drug Action, on Enzymes and Drug Action[electronic resource] /editor for the Co-ordinating Committee, J.L. Mongar ; editor for the Ciba Foundation, A.V.S. de ReuckBoston Little, Brown19621 online resource (581 p.)Ciba Foundation symposiumDescription based upon print version of record.0-470-72269-X Includes bibliographical references and indexes.ENZYMES AND DRUG ACTION; CONTENTS; Wellcome Building Sessions; Session 1: Enzymes as Primary Points of Drug Action; Chairman's introduction; Inhibition of acetylcholinesterase; Discussion; Carbonic anhydrase inhibition and physiological function; Discussion; Session 2: Active Transport; Pinocytosis; Discussion; Possible mechanisms of active transport; Discussion; Effects of drugs on active transport; Discussion; Session 3: Multiple Mechanisms; I. Insulin; The explanation of the action of insulin on sugar permeability at molecular level; Action of insulin on metabolic reactions; DiscussionII. DigitalisAction of cardiac glycosides on ionic movements; Digitalis: action on metabolism and the contractile system; Discussion; III. Central Nervous System Depressants; Action of barbiturates upon respiratory enzymes; Appraising enzymic actions of central depressants by examining cerebral tissues; Discussion; Session 4: Receptors; Relation between enzymes and cholinergic receptors; Discussion; Induction of receptors; Discussion; Session 5: Altered Drug Metabolism; Chairman's introduction; Adaptive enzymes in animals; Discussion; Drug tolerance; DiscussionThe genetics of drug sensitivity with special reference to suxamethoniumDiscussion; Session 6: Drug Metabolism: Subcellular Aspects; Drug metabolism-subcellular mechanisms; Discussion; Cellular injury by drugs; Protection against cellular injury by drugs; Discussion; Panel Discussion; Ciba Foundation Sessions on Drug-Enzyme Interaction at the Molecular Level; Session 1: Enzymes; Introduction: Enzymes; Models of active centres: acetylcholine; Active transport; Mode of action of insulin; Limitations of enzymes as models; Session 2: Receptors; Introduction: Receptors; Definition of receptorsIdentifying active centresEffect of denervation on receptors; Events at the cell membrane; Rate theory of drug action; Interaction at the Subcellular and Cellular Levels; Session 3: Subcellular Level; Introduction: Membranes; Subcellular particles; Phosphatidic acid cycle; Antihistamines and membrane permeability; Drug concentrations in vitro; Session 4: Cellular Level; Introduction: Cellular aspects; Reconstituting in vitro; In vitro and in vivo; Microsomal enzymes; Endoplasmic reticulum; Enzymes in young animals; Transaminase and GABA; Drug interactions; General considerationsCiba Foundation symposium.EnzymesCongressesDrugsPhysiological effectCongressesDrugsMetabolismCongressesElectronic books.EnzymesDrugsPhysiological effectDrugsMetabolism612.0151Mongar J. L867781De Reuck Anthony V. S290946Biological Council.Co-ordinating Committee for Symposia on Drug Action.MiAaPQMiAaPQMiAaPQBOOK9910144848503321Ciba Foundation Symposium, jointly with Co-ordinating Committee for Symposia on Drug Action, on Enzymes and Drug Action1936871UNINA